购物车
- 全部删除
- 您的购物车当前为空
Fenbufen (Lederfen) 是一种非甾体抗炎药,主要用于治疗骨关节炎、强直性脊柱炎和肌腱炎的炎症。它还可用于缓解背痛、扭伤和骨折,具有 caspases 的抑制活性。它对 COX-1和 COX-2具有抑制活性,其 IC50分别为 3.9 μM 和 8.1 μM。
为众多的药物研发团队赋能,
让新药发现更简单!
Fenbufen (Lederfen) 是一种非甾体抗炎药,主要用于治疗骨关节炎、强直性脊柱炎和肌腱炎的炎症。它还可用于缓解背痛、扭伤和骨折,具有 caspases 的抑制活性。它对 COX-1和 COX-2具有抑制活性,其 IC50分别为 3.9 μM 和 8.1 μM。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
25 mg | ¥ 132 | 现货 | |
50 mg | ¥ 178 | 现货 | |
100 mg | ¥ 247 | 现货 | |
500 mg | ¥ 572 | 现货 | |
1 g | ¥ 837 | 现货 | |
1 mL x 10 mM (in DMSO) | ¥ 272 | 现货 |
产品描述 | Fenbufen (Lederfen) is a non-steroidal anti-inflammatory drug used primarily to treat inflammation in osteoarthritis, ankylosing spondylitis, and tendinitis. It can also be used to relieve backaches, sprains, and fractures. Fenbufen is available as a capsule or tablet sold with the brand names Cepal, Cinopal, Cybufen, Lederfen, and Reugast. Fenbufen acts by preventing cyclooxygenase from producing prostaglandins which can cause inflammation. |
靶点活性 | ATP systhesis:0.88 μM(Ki) |
体内活性 | Fenbufen and its metabolites could be involved in mitochondrial toxicity through inhibition of ATP synthesis[1]. Fenbufen inhibited prostaglandin release by 80% and reduced rates of protein synthesis in normal muscle and in muscle undergoing hypertrophy in response to tenotomy of a synergist[3]. |
别名 | 芬布芬, Lederfen, CL-82204 |
分子量 | 254.28 |
分子式 | C16H14O3 |
CAS No. | 36330-85-5 |
Smiles | C(CCC(O)=O)(=O)C1=CC=C(C=C1)C2=CC=CC=C2 |
密度 | 1.1565 g/cm3 (Estimated) |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
溶解度信息 | Ethanol: 47 mg/mL (184.8 mM) DMSO: 47 mg/mL (184.8 mM) H2O: < 1 mg/mL (insoluble or slightly soluble) | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
Ethanol/DMSO
|
评论内容